title: Mirtazapine treatment and sexual functions: Results of a Hungarian, multicentre, prospective study in depressed out-patients.
abstract: Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab®) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.
authors.affiliation: Department of Psychiatry, University of Pecs, Pecs, Hungary.
authors.forename: Peter
authors.initials: P
authors.lastname: Osváth
authors.forename: Sandor
authors.initials: S
authors.lastname: Fekete
authors.forename: Viktor
authors.initials: V
authors.lastname: Vörös
authors.forename: Janos
authors.initials: J
authors.lastname: Almási
keywords: Depression; mirtazapine (Remeron SolTab®); prospective study; sexual dysfunction